Cart
sales@molnova.com
Ned 19
CAS No. 874374-25-1
Ned 19( —— )
Catalog No. M33037 CAS No. 874374-25-1
Ned 19, a selective membrane-permeant non-competitive antagonist of NAADP, strongly inhibits tumor growth, vascularization, and lung metastases in mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | Get Quote |
|
| 5MG | 132 | Get Quote |
|
| 10MG | 202 | Get Quote |
|
| 25MG | 330 | Get Quote |
|
| 50MG | 490 | Get Quote |
|
| 100MG | 683 | Get Quote |
|
| 500MG | 1377 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNed 19
-
NoteResearch use only, not for human use.
-
Brief DescriptionNed 19, a selective membrane-permeant non-competitive antagonist of NAADP, strongly inhibits tumor growth, vascularization, and lung metastases in mice.
-
DescriptionNed 19 is a selective membrane-permeant non competitive NAADP antagonist and inhibits NAADP-mediated Ca2+ signaling, with anIC50 of 65 nM. Ned 19 strongly inhibits tumor growth and vascularization as well as lung metastases in mice.
-
In VitroNed 19 (25-100 μM; 24-72?hours) reduces cell proliferation.Ned 19 (25-100 μM; 24-72?hours) reduces markedly the cell number.Ned 19 (25-100 μM; 24-72?hours) reduces the S phase percentage and increases of the G0/G1 phase percentage evaluated by cell cycle analysis. Ned 19 (25-100 μM; 24-72?hours) induces cell apoptosis a time-dependent manner. Ned 19 (25-100 μM; 24-72?hours) reduces expression of N-cadherin and increases expression of E-cadherin, affecting the cell migratory behavior. Cell Proliferation Assay Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced cell proliferation.Cell Viability Assay Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced markedly the cell number. Cell Cycle Analysis Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced the S phase percentage and increased of the G0/G1 phase percentage.Apoptosis AnalysisCell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Induced cell apoptosis a time-dependent manner.Western Blot Analysis Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced expression of N-cadherin and increased expression of E-cadherin.
-
In VivoNed 19 (i.p.; 5?mg/Kg/every second day; 4 week) impaires severely tumor growth. Animal Model:Adult male C57BL/6 mice Dosage:5?mg/Kg Administration:I.p.; every second day; 4 week Result:Impaired severely tumor growth.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number874374-25-1
-
Formula Weight514.59
-
Molecular FormulaC30H31FN4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (242.91 mM; Ultrasonic )
-
SMILESC(O)(=O)C1CC2=C(C(N1)C3=CC(CN4CCN(CC4)C5=C(F)C=CC=C5)=C(OC)C=C3)NC=6C2=CC=CC6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rosen D, et al. Analogues of the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonistNed-19 indicate two binding sites on the NAADP receptor. J Biol Chem. 2009 Dec 11;284(50):34930-4.?
molnova catalog
related products
-
DS16570511 B
DS16570511 is a novel, cell-permeable inhibitor targeting the mitochondrial calcium uniporter. It effectively blocks the increase in Ca2+ influx dependent on MCU or MICU1 .
-
Equilin
Equilin (7-Dehydroestrone) is a neurotrophic estrogenic steroid with vasodilatory activity that increases monocyte-endothelial adhesion through NF-κB signalling.
-
Etripamil
Etripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel.
